Startups
Prellis Bio 2024-0906-
Prellis Bio is Future Ventures’ new investment this week, funding an army of synthetic human lymph nodes to identify, amplify, and manufacture antibody therapies for <a href="https://www.prellisbio.com/covid" rel="noreferrer nofollow">COVID-19</a> and potentially all new pandemic diseases (viral and bacterial). You can think of it as a surrogate human immune system, without needing any infected patients to sample from. They have already shown that this works for Zyka. Let's call it an "Immune System as a Service" (ISaaS) From the Prellis Bio <a href="https://9f804ddd-16fe-44a8-99a9-29dc8fe08b27.filesusr.com/ugd/262249_3383d2070790478a8b11189e93f7123c.pdf" rel="noreferrer nofollow">white paper</a> on the Externalized Immune System: "Viral drift, or mutagenesis, keep
Team
No team members on record yet.